Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Lalloo

Showing results (61-70 of 162) with videos related to

Pageof 17
Sort By:
Journal of Medical Genetics|December 20, 2023
Germline testing of <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i> and <i>CHEK2</i> c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of <i>ATM</i>, <i>RAD51C</i> and <i>RAD51D</i> in over 400Emma R Woodward, Fiona Lalloo, Claire Forde, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesFiona Lalloo, Jennifer Varley, Anthony Moran, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2020
BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort studySarah J Kitson, Cemsel Bafligil, Neil A J Ryan, et al.
Journal of Medical Genetics|November 19, 2025
Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancerD Gareth Evans, Robert D Morgan, Claire Forde, et al.
International Journal of Cancer|August 1, 2013
A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancerDavid Mesher, Isis Dove-Edwin, Peter Sasieni, et al.
Breast (Edinburgh, Scotland)|August 31, 2021
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancerD Gareth Evans, Ashu Gandhi, Julie Wisely, et al.
Journal of Medical Genetics|April 13, 2023
Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancerD Gareth Evans, George J Burghel, Helene Schlecht, et al.
Gut|June 24, 2020
Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemicKevin J Monahan, Anne Lincoln, James E East, et al.
Journal of Medical Genetics|September 12, 2020
Assessment of mismatch repair deficiency in ovarian cancerEmma J Crosbie, Neil A J Ryan, Rhona J McVey, et al.
Cancers|February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast CancerZerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
Pageof 17

Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Journal of Medical Genetics|December 20, 2023
Germline testing of <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i> and <i>CHEK2</i> c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of <i>ATM</i>, <i>RAD51C</i> and <i>RAD51D</i> in over 400Emma R Woodward, Fiona Lalloo, Claire Forde, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relativesFiona Lalloo, Jennifer Varley, Anthony Moran, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2020
BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort studySarah J Kitson, Cemsel Bafligil, Neil A J Ryan, et al.
Journal of Medical Genetics|November 19, 2025
Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancerD Gareth Evans, Robert D Morgan, Claire Forde, et al.
International Journal of Cancer|August 1, 2013
A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancerDavid Mesher, Isis Dove-Edwin, Peter Sasieni, et al.
Breast (Edinburgh, Scotland)|August 31, 2021
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancerD Gareth Evans, Ashu Gandhi, Julie Wisely, et al.
Journal of Medical Genetics|April 13, 2023
Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancerD Gareth Evans, George J Burghel, Helene Schlecht, et al.
Gut|June 24, 2020
Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemicKevin J Monahan, Anne Lincoln, James E East, et al.
Journal of Medical Genetics|September 12, 2020
Assessment of mismatch repair deficiency in ovarian cancerEmma J Crosbie, Neil A J Ryan, Rhona J McVey, et al.
Cancers|February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast CancerZerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
Pageof 17